Peptide record

TPDB47420

ACE inhibitor from b-CN (47-59) mouse ACE inhibitors Antihypertensive standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB47420
ACE inhibitor from b-CN (47-59) mouse
ACE inhibitors Antihypertensive
Cardiometabolic peptides
pep-lab Peptipedia AHTPDB AHTpin
standard
No
A 13-aa standard natural multi-activity (ACE inhibitors and Antihypertensive) peptide sequence curated from pep-lab, Peptipedia, AHTPDB, and other sources, with an available 3D structural model.
Sequence
VHSSIQSQPQAFT
Physicochemical Analysis
C62H96N18O21
RNDCEGLKMWY
QS
1429.55
7.85
1
0
4
+0
2.14
-0.392
60.00
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
7
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
3
Q
0
G
1
H
1
I
0
L
0
K
0
M
1
F
1
P
3
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 3 G: 0 H: 1 I: 1 L: 0 K: 0 M: 0 F: 1 P: 1 S: 3 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
13
C62H96N18O21
1429.55
7.85
+0
2.14
-0.392
1429.5298
1428.6975
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
1001.00 µM
ACE inhibitor
ah

Source & Reference

NA
Meisel H., Walsh D. J., Murray B., FitzGerald R. J.
ACE inhibitory peptides. in: Nutraceutical proteins and peptides in health and disease. Mine Y., Shahidi F. (Eds.), CRC Taylor & Francis Group, Boca Raton, London, New York, 269-315.
2006
book

Other

13
EC50>1000
Evidence 2 Activity

Activity

IC50
Antihypertensive
1001.00 µM
ACE inhibitor
ah

Source & Reference

AHTPDB
Meisel H., Walsh D. J., Murray B., FitzGerald R. J.
ACE inhibitory peptides. in: Nutraceutical proteins and peptides in health and disease. Mine Y., Shahidi F. (Eds.), CRC Taylor & Francis Group, Boca Raton, London, New York, 269-315.
2006
book

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
13
EC50>1000
Additional Detail Fields 1 fields
13